Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

Forecast Balance Sheet - Albemarle Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,955 1,718 3,277 2,324 1,576 425 -460 -1,117
Change - -12.12% 90.75% -29.08% -32.19% -73.03% -208.24% -142.83%
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 953.7 1,262 2,149 1,686 589.8 346.9 504.8 652.3
Change - 32.29% 70.36% -21.56% -65.01% -41.18% 45.53% 29.21%
Free Cash Flow (FCF) 1 -609.4 646.2 -824 -983.7 692.5 1,424 1,258 1,168
Change - 206.04% -227.51% -19.39% 170.39% 105.7% -11.68% -7.16%
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.17% 47.48% 35.05% 21.2% 21.35% 43.31% 39.39% 40.7%
EBIT Margin (%) 18.54% 43.37% 30.57% 10.25% 8.54% 24.98% 24.03% 25.2%
EBT Margin (%) 4.02% 33.24% 2.57% -32.8% -10.74% 17.13% 14.11% 26.69%
Net margin (%) 3.72% 36.75% 16.36% -24.47% -13.17% 17.91% 18.97% 30.13%
FCF margin (%) -18.31% 8.83% -8.57% -18.29% 13.46% 23.62% 21.49% 18.69%
FCF / Net Income (%) -492.76% 24.02% -52.37% 74.75% -102.23% 131.9% 113.31% 62.03%

Profitability

        
ROA 4.39% 19.57% 15.54% -1.58% -0.56% 7.7% 6.53% 9.74%
ROE 8.31% 19.01% 30.12% -2.84% -0.95% 13.17% 9.18% 10.97%

Financial Health

        
Leverage (Debt/EBITDA) 2.24x 0.49x 0.97x 2.04x 1.43x 0.16x - -
Debt / Free cash flow -3.21x 2.66x -3.98x -2.36x 2.28x 0.3x - -

Capital Intensity

        
CAPEX / Current Assets (%) 28.66% 17.24% 22.35% 31.35% 11.47% 5.75% 8.62% 10.44%
CAPEX / EBITDA (%) 109.49% 36.3% 63.77% 147.91% 53.72% 13.28% 21.9% 25.65%
CAPEX / FCF (%) -156.49% 195.24% -260.85% -171.37% 85.17% 24.35% 40.13% 55.85%

Items per share

        
Cash flow per share 1 2.972 16.2 11.25 5.974 10.9 14.74 11.96 12.73
Change - 445.01% -30.52% -46.91% 82.41% 35.27% -18.85% 6.45%
Dividend per Share 1 1.56 1.58 1.6 1.61 1.62 1.626 1.653 1.669
Change - 1.28% 1.27% 0.63% 0.62% 0.36% 1.65% 0.99%
Book Value Per Share 1 48.07 67.77 80.17 84.74 80.99 84.49 91.93 98.55
Change - 40.97% 18.3% 5.69% -4.43% 4.33% 8.81% 7.2%
EPS 1 1.06 22.84 13.36 -11.2 -5.76 8.342 7.833 11.49
Change - 2,054.72% -41.51% -183.83% 48.57% 244.83% -6.11% 46.7%
Nbr of stocks (in thousands) 116,976 117,153 117,353 117,540 117,698 118,010 118,010 118,010
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 9.94x 10.6x
PBR 0.98x 0.9x
EV / Sales 1.69x 1.59x
Yield 1.96% 1.99%

EPS & Dividend

EPS & Dividend - Albemarle Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Albemarle Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Albemarle Corporation
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Albemarle Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
82.93USD
Average target price
140.55USD
Spread / Average Target
+69.48%
  1. Stock Market
  2. Stocks
  3. ALB Stock
  4. Financials Albemarle Corporation